UGT1A8 - UDP glucuronosyltransferase family 1 member A8 Gene
Also Known as GNT1; UGT1; UDPGT; UGT1A; UGT1H; UGT-1A; UGT-1H; UGT1.1; UGT1.8; UGT1A1; UGT1-01; UGT1-08; UGT1A8S; hUG-BR1; UDPGT 1-1; UDPGT 1-8
Species: Homo sapiens
About UGT1A8
This gene has 1 transcript (splice variant), 1221 orthologues and 21 paralogues.
Summary
This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as Steroids, bilirubin, Hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has glucuronidase activity with many substrates including Coumarins, Phenols, Anthraquinones, Flavones, and some opioids. [provided by RefSeq, Jul 2008]
UGT1A8 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_019076.5 | NP_061949.3 | UDP-glucuronosyltransferase 1A8 precursor |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables enzyme binding |
IPI
IPI: Inferred from physical interaction
|
17179145 | GOA |
| enables enzyme inhibitor activity |
IDA
IDA: Inferred from direct assay
|
19996319 | GOA |
| enables enzyme inhibitor activity |
IGI
IGI: Inferred from genetic interaction
|
20610558 | GOA |
| enables fatty acid binding |
IDA
IDA: Inferred from direct assay
|
19996319 | GOA |
| enables glucuronosyltransferase activity |
IDA
IDA: Inferred from direct assay
|
18052087 | GOA |
| NOT enables glucuronosyltransferase activity |
IGI
IGI: Inferred from genetic interaction
|
20610558 | GOA |
| enables protein heterodimerization activity |
IPI
IPI: Inferred from physical interaction
|
20610558 | GOA |
| enables protein homodimerization activity |
IDA
IDA: Inferred from direct assay
|
17179145 | GOA |
| enables steroid binding |
IDA
IDA: Inferred from direct assay
|
19996319 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in cellular glucuronidation |
IDA
IDA: Inferred from direct assay
|
20610558 | GOA |
| involved in fatty acid metabolic process |
IDA
IDA: Inferred from direct assay
|
20610558 | GOA |
| involved in flavone metabolic process |
IDA
IDA: Inferred from direct assay
|
18052087 | GOA |
| involved in flavonoid glucuronidation |
IDA
IDA: Inferred from direct assay
|
20056724 | GOA |
| involved in negative regulation of cellular glucuronidation |
IDA
IDA: Inferred from direct assay
|
20610558 | GOA |
| involved in negative regulation of fatty acid metabolic process |
IDA
IDA: Inferred from direct assay
|
20610558 | GOA |
| involved in steroid metabolic process |
IDA
IDA: Inferred from direct assay
|
15472229 | GOA |
| involved in xenobiotic glucuronidation |
IDA
IDA: Inferred from direct assay
|
20056724 | GOA |
| NOT involved in xenobiotic metabolic process |
IDA
IDA: Inferred from direct assay
|
20610558 | GOA |
| involved in xenobiotic metabolic process |
IDA
IDA: Inferred from direct assay
|
20610558 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in endoplasmic reticulum |
IDA
IDA: Inferred from direct assay
|
17179145 | GOA |
UGT1A8 Protein Structure
UDPGT: UDP-glucoronosyl and UDP-glucosyl transferase (26 - 521)
- 0
- 100
- 200
- 300
- 400
- 500
- 530 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
UDP-glucuronosyltransferase 1A8 |
|
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Bilirubin Metabolic Disorder |
|
|
| Gilbert Syndrome |
|
|
| Crigler-Najjar Syndrome, Type I |
|
|
| Bilirubin, Serum Level Of, Quantitative Trait Locus 1 |
|
|
| Hyperbilirubinemia, Transient Familial Neonatal |
|
|
| Crigler-Najjar Syndrome, Type Ii |
|
|
| Cholelithiasis |
|
|
| Kernicterus |
|
|
| Pigmentation Disease |
|
|
| Epicardium Cancer |
|
|
| Neonatal Jaundice |
|
|
| Dihydropyrimidine Dehydrogenase Deficiency |
|
|
| Blood Group Incompatibility |
|
|
| Coumarin Resistance |
|
|
| Cardiomyopathy, Dilated, With Hypergonadotropic Hypogonadism |
|
|
| Glucosephosphate Dehydrogenase Deficiency |
|
|
| Thiopurines, Poor Metabolism Of, 1 |
|
|
| Nephrotic Syndrome, Type 20 |
|
|
| Hereditary Spherocytosis |
|
|
| Autosomal Dominant Beta Thalassemia |
|
|
| Sickle Cell Anemia |
|
|
| Alpha-Thalassemia |
|
|